U.S. overdose deaths involving psychostimulants other than cocaine, largely methamphetamine, increased 180% among adults under age 65 between 2015 and 2019, to 15,489, according to a study by the National Institute on Drug Abuse published this week in JAMA Psychiatry. The number of people reporting methamphetamine use increased 43% over the period, suggesting that increases in methamphetamine use disorder, frequent use and use of other drugs at the same time may be contributing to the rise in deaths, the authors said.

“What makes these data even more devastating is that currently, there are no approved medications to treat methamphetamine use disorder,” said Emily Einstein, chief of NIDA’s Science Policy Branch and a co-author of the study. 
 

Headline
The AHA will host a webinar June 16 at 1 p.m. ET that will share insights from its Bridge to Care Toolkit, designed to help hospitals and health systems…
Headline
The Drug Enforcement Administration today released a final rule implementing provisions from the Restoring Hope for Mental Health and Well-Being Act of 2022,…
Headline
 The AHA has won two Telly Awards for its three-part video series, Voices of Leadership: Breaking Mental Health Stigma. The Telly Awards, a global…
Headline
In this conversation, three leaders from CommonSpirit Health explore how the organization is confronting stigma about substance use head-on through education,…
Headline
The Health Resources and Services Administration will award grants to rural hospitals and other providers from two areas of its Rural Communities Opioid…
Perspective
Public
May is Mental Health Awareness Month, a time to elevate a conversation that hospitals and health systems live every day. Behavioral health is inseparable from…